Brief: Klaria Pharma Announces Patent Approval In Europe
Feb 5 (Reuters) - Klaria Pharma Holding AB (publ) KLAR.ST :
* KLARIA ANNOUNCES PATENT APPROVAL IN EUROPE OF A NEW
PRODUCT
PATENT COVERING NALOXONE ALGINATE FILM
* COMPLETELY NEW PATENT THAT WILL GRANT NALOXONE ALGINATE
FILM
MARKET EXCLUSIVITY IN EU UNTIL 2037
Source text for Eikon: ID:nWkr84wRht
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement